TNDM

Tandem Diabetes Care, Inc.

31.21 USD
+3.63 (+13.16%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tandem Diabetes Care, Inc. stock is up 36.29% since 30 days ago. The next earnings date is May 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 March’s closed higher than February. In the last 8 Unusual Options Trades, there were 4 PUTs, 4 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jan 18:46 19 Jan, 2024 30.00 PUT 180 818
06 Feb 18:30 15 Mar, 2024 25.00 CALL 198 25
06 Feb 18:32 17 May, 2024 27.50 CALL 183 47
14 Feb 17:19 17 May, 2024 32.50 CALL 208 37
16 Feb 18:54 15 Mar, 2024 22.50 PUT 425 566
21 Feb 14:44 15 Mar, 2024 22.50 PUT 250 801
22 Feb 17:36 16 Aug, 2024 12.50 PUT 500 7
27 Feb 14:46 19 Apr, 2024 22.50 CALL 50 123

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.